|
End-of-day quote
Thailand S.E.
28/08/2026
|
5-day change | 1st Jan Change | ||
| 4.840 THB | -1.63% |
|
-6.02% | -32.78% |
Company Valuation: Healthlead
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Market Cap 1 | 4,923 | 6,691 | 2,829 | 2,774 | 1,886 |
| Change | - | 35.91% | -57.72% | -1.92% | -32.02% |
| Enterprise Value (EV) 1 | 4,332 | 6,205 | 2,495 | 2,554 | 1,655 |
| Change | - | 43.25% | -59.79% | 2.37% | -35.2% |
| P/E | 46.9x | 56.6x | 37.9x | 35.4x | 24.8x |
| PBR | 5.69x | 7.1x | 2.92x | 2.76x | 1.95x |
| PEG | 2.3x | 4.5x | -1x | 7.37x | 31.41x |
| Capitalization / Revenue | 4.05x | 4.35x | 1.7x | 1.38x | 0.83x |
| EV / Revenue | 3.56x | 4.03x | 1.5x | 1.27x | 0.73x |
| EV / EBITDA | 37x | 38.1x | 19.8x | 19.5x | 10.8x |
| EV / EBIT | 42.2x | 41.8x | 24.8x | 26.8x | 15x |
| EV / FCF | 87.9x | -737x | -156x | 830x | 11.7x |
| FCF Yield | 1.14% | -0.14% | -0.64% | 0.12% | 8.55% |
| Dividend per Share 2 | 0.28 | 0.18 | 0.15 | 0.17 | 0.22 |
| Rate of return | 1.55% | 0.73% | 1.44% | 1.67% | 3.06% |
| EPS 2 | 0.3861 | 0.4347 | 0.2746 | 0.2877 | 0.29 |
| Distribution rate | 72.5% | 41.4% | 54.6% | 59.1% | 75.9% |
| Net sales 1 | 1,216 | 1,538 | 1,659 | 2,011 | 2,270 |
| EBITDA 1 | 117.1 | 163 | 126.3 | 131.3 | 153.5 |
| EBIT 1 | 102.6 | 148.4 | 100.7 | 95.39 | 110.6 |
| Net income 1 | 79.66 | 118.2 | 74.68 | 78.26 | 77.86 |
| Net Debt 1 | -591.5 | -486 | -333.6 | -220.1 | -230.9 |
| Reference price 2 | 18.100 | 24.600 | 10.400 | 10.200 | 7.200 |
| Nbr of stocks (in thousands) | 272,000 | 272,000 | 272,000 | 272,000 | 261,956 |
| Announcement Date | 25/02/22 | 27/02/23 | 28/02/24 | 28/02/25 | 25/02/26 |
1THB in Million2THB
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 16.78x | 0.68x | 10.1x | -.--% | 14.92B | ||
| 20.98x | 0.8x | 13.48x | 1.07% | 6.48B | ||
| 16.99x | 0.77x | 7.98x | 2.19% | 6.45B | ||
| 14.75x | 0.95x | 7.07x | 3.26% | 4.12B | ||
| 14.61x | 1.25x | 7.66x | 5.51% | 3.25B | ||
| 13.86x | 0.58x | 4.77x | 5.23% | 3.07B | ||
| 13.83x | 0.83x | 6.24x | 4.64% | 2.91B | ||
| 30.19x | - | - | - | 2.35B | ||
| Average | 17.75x | 0.84x | 8.19x | 3.13% | 5.45B | |
| Weighted average by Cap. | 17.40x | 0.79x | 9.13x | 1.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- HL Stock
- HL-R Stock
- Valuation Healthlead
Select your edition
All financial news and data tailored to specific country editions
















